title: Should therapy of ovarian cancer patients be individualized based on underlying genetic defects?
authors.forename: G B
authors.initials: GB
authors.lastname: Mills
authors.forename: R
authors.initials: R
authors.lastname: Schmandt
authors.forename: D
authors.initials: D
authors.lastname: Gershenson
authors.forename: R C
authors.initials: RC
authors.lastname: Bast
mesh_terms: D005260:Female; D006801:Humans; D007206:Individuality; D009693:Nucleic Acid Hybridization; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000235:genetics*; D011237:Predictive Value of Tests